Navigation Links
BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees
Date:12/2/2008

SANTA BARBARA, Calif., Dec. 2 /PRNewswire/ -- BioIQ, the leader in consumer-friendly health testing products and services, and Alere(R), who provides services that include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions to health plans, employers, and government agencies, will work together to supply BioIQ's home-test kits and online reporting tools as part of Alere's Personal Health Solutions.

"In today's increasingly virtual world, more employees are working remotely, either from home or satellite locations," said Dr. Ron Geraty, CEO of Alere. "By identifying risk factors early, we can in many cases minimize the impact of conditions such as diabetes, heart disease, hypertension and obesity. With this expanded Screening Services offering, Alere will be able to reach both employees and dependents more effectively."

As part of this workplace-wellness initiative, participants of Alere's Screening Services Programs will order BioIQ test kits via a secure website, which are then mailed to their homes. Each kit includes instructions for drawing a small blood sample through a simple finger-prick method and mailing it to a certified laboratory for analysis. Measurements include high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, triglycerides, hemoglobin/A1c, and fasting glucose. A single-sign-on login process will enable Alere participants to seamlessly access BioIQ's enrollment and lab results pages via secure personal accounts. In addition, the results from the BioIQ tests will be automatically loaded into each participant's Health & Productivity Assessment and Personal Health Record, which are part of Alere's Wellness Solutions.

"BioIQ adds to Alere's current on-site and in-home screening offering, enabling them to screen more people and more effectively identify health risks," said Justin Bellante, CEO at BioIQ. "Biometric testing leads to more effective interventions, treatment, and follow-up."

About BioIQ

BioIQ (www.bioiq.com) is a healthcare information technology company that develops and markets medical diagnostic solutions through corporate, institutional and direct-to-consumer channels. The company's affordable and innovative home test kits are commonly used to monitor or screen for diabetes, cancer, heart disease, kidney disease, thyroid disorder, osteoporosis, and other chronic health conditions.

About Alere

Alere is a member of the Inverness Medical Innovations (www.invernessmedical.com) family of companies and represents the union of Alere Medical, ParadigmHealth and Matria(R) Healthcare. Alere is the Latin verb meaning "to care for" or "to support". Services include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions and high-risk pregnancy and NICU management. In addition, in-home diagnostics monitoring devices address the need for the daily monitoring of medium- and high-risk patients. Inverness Medical Innovations is a global leader in rapid point-of-care diagnostics, cardiology, oncology, women's health and health management services. More information can be found about Alere at www.alere.com.

(C) 2008 Inverness Medical. All rights reserved. Alere and Matria are trademarks of the Inverness Medical group of companies.


'/>"/>
SOURCE BioIQ
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Software Vendor QAD Rolls Out BioIQ Health Testing Program to National Workforce
2. Inverness Medical Innovations Acquires Alere Medical
3. Avalere Study Shows Medicare Part D Helping People with Type 2 Diabetes; Warns People with Diabetes of Probability of Reaching the Donut Hole
4. Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans
5. Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File
6. Avalere Examines Emerging Strategies for Managing Imaging Utilization
7. Study provides hope that some transplant patients could live free of antirejection drugs
8. Study provides hope that some transplant patients could live free of anti-rejection drugs
9. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
10. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
11. USAID Provides Additional Wildfire Assistance to Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology: